The Asthma Disease Market was valued at approximately USD 25 Billion in 2023 and is expected to grow at a strong CAGR of around ~5% during the forecast period (2024-2032) owing to the robust pipeline activity, advancements in genetic research, and patient-centered drug development. Asthma is characterized by inflammation of the airways evident by reversible airway obstruction and bronchospasm....

"Executive Summary Allergic Asthma Disease Market :  The expected CAGR of global allergic asthma disease market is tend to be around 3% in the mentioned forecast period. The market was valued at USD 7 billion in 2021, and it would grow upto USD 8.87 billion by 2029.    The Allergic Asthma Disease Market report includes a range of inhibitors as well as driving...